111.59 0.00 (0.00%)
After hours: 4:23PM EST
|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||109.81 - 111.79|
|52 Week Range||61.37 - 111.95|
|PE Ratio (TTM)||22.89|
|Earnings Date||Feb 6, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||118.58|
The Health Maintenance Organization (HMO) industry has consistently outperformed the S&P 500 over the last five years with its 285.2% appreciation, easily trumping the S&P 500’s 90.2%. But the industry started pulling even further ahead in 2015 and again after the election of President Donald Trump. HMOs have been around for ages, but their prominence in recent years is related to rising medical costs with the consequent pressure on insurers’ profitability and the belief that timely checkups and preventive services can reduce expenditure. Services from other medical professionals are generally not covered by the HMO.
ST. LOUIS, Jan. 22, 2018 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that its New Mexico subsidiary, Western Sky Community Care, has been awarded a statewide contract in New Mexico for the Centennial Care 2.0 Program. The state's current program, Centennial Care, provides integrated Medicaid managed care coverage, including long-term services and supports (LTSS) and behavioral health, to nearly 700,000 Medicaid members in the state. "We look forward to working with the state of New Mexico to build on the success of the existing Centennial Care program," said Michael F. Neidorff, Chairman and CEO for Centene.
Given that repealing and replacing Obamacare was on the top of the Trump administration’s agenda, the healthcare sector exited 2017 quite creditably. The all too familiar factors of an ageing population and steady demand for healthcare services, irrespective of economic conditions, continue to make stocks from the sector a lucrative option. Further, earnings and revenues from the sector are likely to improve in the fourth quarter, which makes it a good idea to pick up select healthcare stocks which are also slated to outperform their earnings estimates.
Molina Healthcare, Inc. (NYSE: MOH ) and CEO Joe Zubretsky made quite an impression at the recent JPMorgan Healthcare conference , and Wall Street took notice. The Analyst JPMorgan analyst Gary Taylor ...
CVS Health's (CVS) strong Pharmacy Services business continues to gain from a sturdy Specialty Pharmacy. However, its highly competitive retail pharmacy business raises concern.
Shares of Tenet Healthcare (THC) have lost significantly last year owing to lower revenues, weak margins, high bad debts and expenses.
Boston Scientific (BSX) claims its Spectra WaveWriter Spinal Cord Stimulator System to combine both paresthesia-based and sub-perception therapies to target a specific area of pain.
Centene Corp., the health insurer that the city of Sacramento has agreed to pay $13.5 million in economic incentives to build a local campus, is facing a lawsuit claiming that it doesn't provide adequate access to doctors in 15 states, The New York Times reported . People who bought policies from Centene (CNC) filed the federal lawsuit on Thursday, according to The New York Times. “Members have difficulty finding — and in many cases cannot find — medical providers” who will accept patients covered under policies sold by Centene, the lawsuit claims.
Abaxis' (ABAX) growing portfolio of rapid test menu and a strong performance in Veterinary consumables drive growth. Intense competition in both the Medical and Veterinary markets is a concern.
Stryker Corporation's (SYK) fourth quarter and 2017 preliminary net sales figures are encouraging, courtesy of balanced revenue growth in all business segments.
Centene Corp. misled customers about the number of doctors covered under its health plans, offering individuals who bought Obamacare plans far skimpier coverage than they signed up for, according to a ...
Intuitive Surgical (ISRG) optimistic about fourth-quarter and 2017 net sales outcome on revenue growth across all business segments.
Masimo (MASI) states that with its inherent touchscreen interface, Rad-97 is user-friendly for clinicians and non-clinicians and can be easily tailored to cater to the needs of home users.
Teladoc's (TDOC) impressive fourth-quarter preliminary results and 2018 guidance reflects the company's solid business growth.
Jan.09 -- Michael Neidorff, Centene chief executive officer, talks with Bloomberg's Erik Schatzker about the future of U.S. health-care policy at the JPMorgan Health-Care Conference on "Bloomberg Markets."